StonvexLoading…
StonvexStonvexStonvexCore line items from THG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.70B | $6.59B | $4.92B | $3.26B |
Operating Income | $250.20M | $933.00M | $644.00M | $396.30M |
Net Income | $186.80M | $662.50M | $464.00M | $285.30M |
EPS (Diluted) | $5.20 | $18.16 | $12.70 | $7.80 |
Total Assets | $16.53B | $16.95B | $16.77B | $15.73B |
Total Liabilities | $12.96B | $13.37B | $13.35B | $12.52B |
Cash & Equivalents | $243.50M | $1.12B | $915.70M | $244.10M |
Free Cash Flow OCF − CapEx | $115.30M | $1.17B | $793.40M | $242.00M |
Shares Outstanding | 35.90M | 36.50M | 36.50M | 36.60M |